Analysis of glycosyltransferase expression in metastatic prostate cancer cells capable of rolling activity on microvascular endothelial (E)-selectin

Glycobiology

Volumn 18, Issue 10, 2008, Pages 806-817

  Barthel, Steven R ^a,b   Gavino, Jacyln D ^a   Wiese, Georg K ^a   Jaynes, Jennifer M ^a   Siddiqui, Javed ^c   Dimitroff, Charles J ^a,b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF MICHIGAN COMPREHENSIVE CANCER CENTER   (United States)

Author keywords

E selectin; Fucosyltransferase; Metastasis; Prostate cancer; Sialyl Lewis X

Indexed keywords

ALPHA 1,3 FUCOSYLTRANSFERASE; CARBOHYDRATE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; FUCOSYLTRANSFERASE; FUCOSYLTRANSFERASE3; GALACTOSYLTRANSFERASE; GLYCOPROTEIN; GLYCOSYLTRANSFERASE; N ACETYLGLUCOSAMINYLTRANSFERASE; PADGEM PROTEIN; SIALYL LEWIS X ANTIGEN; SIALYLTRANSFERASE; UNCLASSIFIED DRUG;

ARTICLE; BINDING AFFINITY; BONE METASTASIS; CANCER CELL; CELL ADHESION; CELL ASSAY; CELL INVASION; CELL LINE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; LIGAND BINDING; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN ANALYSIS; PROTEIN CARBOHYDRATE INTERACTION; PROTEIN EXPRESSION; PROTEIN FOLDING; PROTEIN FUNCTION; PROTEIN SYNTHESIS; PROTEIN VARIANT; UPREGULATION;

CELL LINE, TUMOR; E-SELECTIN; ENDOTHELIAL CELLS; GLYCOSYLTRANSFERASES; HUMANS; LIGANDS; MALE; MICROCIRCULATION; NEOPLASM METASTASIS; OLIGOSACCHARIDES; PROSTATIC NEOPLASMS; PROTEIN BINDING;

EID: 53049088661     PISSN: 09596658     EISSN: 14602423     Source Type: Journal    
DOI: 10.1093/glycob/cwn070     Document Type: Article

References (84)

1. Aubert M, Panicot-Dubois L, Crotte C, Sbarra V, Lombardo D, Sadoulet MO, Mas E. 2000. Peritoneal colonization by human pancreatic cancer cells is inhibited by antisense FUT3 sequence. Int J Cancer. 88:558-565.
2. Barthel SR,Gavino JD, Descheny L, Dimitroff CJ. 2007. Targeting selectins and selectin ligands in inflammation and cancer. Expert Opin Ther Targets. 11:1473-1491.
3. Benharroch D, Dima E, Levy A, Ohana-Malka O, Ariad S, Prinsloo I, Mejirovsky E, Sacks M, Gopas J. 2000. Differential expression of sialyl and non-sialyl-CD15 antigens on Hodgkin-Reed-Sternberg cells: Significance in Hodgkin's disease. Leuk Lymphoma. 39:185-194.
4. Benjamin R. 2002. Neurologic complications of prostate cancer. Am Fam Physician. 65:1834-1840.
5. Biol-N'garagba MC, Niepceron E, Mathian B, Louisot P. 2003. Glucocorticoid-induced maturation of glycoprotein galactosylation and fucosylation processes in the rat small intestine. J Steroid Biochem Mol Biol. 84:411-422.
6. Cameron HS, Szczepaniak D, Weston BW. 1995. Expression of human chromosome 19p alpha(1,3)-fucosyltransferase genes in normal tissues. Alternative splicing, polyadenylation, and isoforms. J Biol Chem. 270:20112-20122.
7. Clarke JL, Watkins W. 1996. Alpha1,3-L-fucosyltransferase expression in developing human myeloid cells. Antigenic, enzymatic, and mRNA analyses. J Biol Chem. 271:10317-10328.
8. Clarke JL, Watkins WM. 1997. Independent regulation of Fuc-TIV and Fuc-TVII genes leading to modulation of cell surface antigen expression in developing myeloid cells. Glycobiology. 7:835-846.
9. Clausse N, Van Den Brule F, Waltregny D, Garnier F, Castronovo V. 1999. Galectin-1 expression in prostate tumor-associated capillary endothelial cells is increased by prostate carcinoma cells and modulates heterotypic cell-cell adhesion. Angiogenesis. 3:317-325.
10. Cooper CR, Bhatia JK, Muenchen HJ, McLean L, Hayasaka S, Taylor J, Poncza PJ, Pienta KJ. 2002. The regulation of prostate cancer cell adhesion to human bone marrow endothelial cell monolayers by androgen dihydrotestosterone and cytokines. Clin Exp Metastasis. 19:25-33.
11. Cooper CR, McLean L, Walsh M, Taylor J, Hayasaka S, Bhatia J, Pienta KJ. 2000. Preferential adhesion of prostate cancer cells to bone is mediated by binding to bone marrow endothelial cells as compared to extracellular matrix components in vitro. Clin Cancer Res. 6:4839-4847.
12. Costache M, Apoil PA, Cailleau A, Elmgren A, Larson G, Henry S, Blancher A, Iordachescu D, Oriol R, Mollicone R. 1997. Evolution of fucosyltransferase genes in vertebrates. J Biol Chem. 272:29721-29728.
13. Cress AE, Rabinovitz I, Zhu W, Nagle RB. 1995. The alpha 6 beta 1 and alpha 6 beta 4 integrins in human prostate cancer progression. Cancer Metastasis Rev. 14:219-228.
14. Dabrowska A, Baczynska D, Widerak K, Laskowska A, Ugorski M. 2005. Promoter analysis of the human alpha1,3/4-fucosyltransferase gene (FUT III). Biochim Biophys Acta. 1731:66-73.
15. de Vries T, Knegtel RM, Holmes EH, Macher BA. 2001. Fucosyltransferases: Structure/function studies. Glycobiology. 11:119R-128R.
16. Dimitroff CJ, Descheny L, Trujillo N, Kim R, Nguyen V, Huang W, Pienta KJ, Kutok JL, Rubin MA. 2005. Identification of leukocyte E-selectin ligands, P-selectin glycoprotein ligand-1 and E-selectin ligand-1, on human metastatic prostate tumor cells. Cancer Res. 65:5750-5760.
17. Dimitroff CJ, Lechpammer M, Long-Woodward D, Kutok JL. 2004. Rolling of human bone-metastatic prostate tumor cells on human bone marrow endothelium under shear flow is mediated by E-selectin. Cancer Res 64:5261-5269.
18. Dimitroff CJ, Lee JY, Rafii S, Fuhlbrigge RC, Sackstein R. 2001. CD44 is a major E-selectin ligand on human hematopoietic progenitor cells. J Cell Biol. 153:1277-1286.
19. Ding KF, Zheng S. 2004. Study on relationship of fucosyltransferase gene types in breast cancer with metastasis and prognosis. Zhonghua Wai Ke Za Zhi. 42:546-550.
20. Draffin JE, McFarlane S, Hill A, Johnston PG, Waugh DJ. 2004. CD44 potentiates the adherence of metastatic prostate and breast cancer cells to bone marrow endothelial cells. Cancer Res. 64:5702-5711.
21. Engl T, Relja B, Marian D, Blumenberg C, Muller I, Beecken WD, Jones J, Ringel EM, Bereiter-Hahn J, Jonas D, et al. 2006. CXCR4 chemokine receptor mediates prostate tumor cell adhesion through alpha5 and beta3 integrins. Neoplasia. 8:290-301.
22. Fornaro M, Manes T, Languino LR. 2001. Integrins and prostate cancer metastases. Cancer Metastasis Rev. 20:321-331.
23. Gingrich JR, Barrios RJ, Morton RA, Boyce BF, DeMayo FJ, Finegold MJ, Angelopoulou R, Rosen JM, Greenberg NM. 1996. Metastatic prostate cancer in a transgenic mouse. Cancer Res. 56:4096-4102.
24. Glinsky VV, Glinsky GV, Glinskii OV, Huxley VH, Turk JR, Mossine VV, Deutscher SL, Pienta KJ, Quinn TP. 2003. Intravascular metastatic cancer cell homotypic aggregation at the sites of primary attachment to the endothelium. Cancer Res. 63:3805-3811.
25. Hasegawa T, Sato M, Kurimoto M, Takahashi H, Kawashima T, Matsuo Y, Yamamoto M, Sawai H, Funahashi H, Okada Y, et al. 2005. Biological effect of irradiation on adhesion molecules in human colon cancer cells in vitro. Anticancer Res. 25:875-879.
26. Hidalgo A, Weiss LA, Frenette PS. 2002. Functional selectin ligands mediating human CD34(+) cell interactions with bone marrow endothelium are enhanced postnatally. J Clin Invest. 110:559-569.
27. Higai K, Ishihara S, Matsumoto K. 2006. NFkappaB-p65 dependent transcriptional regulation of glycosyltransferases in human colon adenocarcinoma HT-29 by stimulation with tumor necrosis factor alpha. Biol Pharm Bull. 29:2372-2377.
28. Hiller KM, Mayben JP, Bendt KM, Manousos GA, Senger K, Cameron HS, Weston BW. 2000. Transfection of alpha(1,3)fucosyltransferase antisense sequences impairs the proliferative and tumorigenic ability of human colon carcinoma cells. Mol Carcinog. 27:280-288.
29. Homeister JW, Thall AD, Petryniak B, Maly P, Rogers CE, Smith PL, Kelly RJ, Gersten KM, Askari SW, Cheng G, et al. 2001. The alpha (1,3)fucosyltransferases FucT-IV and FucT-VII exert collaborative control over selectin-dependent leukocyte recruitment and lymphocyte homing. Immunity. 15:115-126.
30. Huang MC, Zollner O, Moll T, Maly P, Thall AD, Lowe JB, Vestweber D. 2000. P-selectin glycoprotein ligand-1 and E-selectin ligand-1 are differentially modified by fucosyltransferases Fuc-TIV and Fuc-TVII in mouse neutrophils. J Biol Chem. 275:31353-31360.
31. Idikio HA. 1997. Sialyl-Lewis-X, Gleason grade and stage in non-metastatic human prostate cancer. Glycoconj J. 14:875-877.
32. Inaba Y, Ohyama C, Kato T, Satoh M, Saito H, Hagisawa S, Takahashi T, Endoh M, Fukuda MN, Arai Y, et al. 2003. Gene transfer of alpha1,3-fucosyltransferase increases tumor growth of the PC-3 human prostate cancer cell line through enhanced adhesion to prostatic stromal cells. Int J Cancer. 107:949-957.
33. Inoue M, Nakada H, Oka Y, Tanaka N, Yamashina I. 1997. Novel glycoproteins inhibiting the binding of colorectal cancer cells to E-selectin. Glycoconj J. 14:147-153.
34. Iwai K, Ishikura H, Kaji M, Sugiura H, Ishizu A, Takahashi C, Kato H, Tanabe T, Yoshiki T. 1993. Importance of E-selectin (ELAM-1) and sialyl Lewis(a) in the adhesion of pancreatic carcinoma cells to activated endothelium. Int J Cancer. 54:972-977.
35. Jorgensen T, Berner A, Kaalhus O, Tveter KJ, Danielsen HE, Bryne M. 1995. Up-regulation of the oligosaccharide sialyl LewisX: A new prognostic parameter in metastatic prostate cancer. Cancer Res. 55:1817-1819.
36. Kannagi R. 2001. Transcriptional regulation of expression of carbohydrate ligands for cell adhesion molecules in the selectin family. Adv Exp Med Biol. 491:267-278.
37. Kannagi R, Hakomori S. 2001. A guide to monoclonal antibodies directed to glycotopes. Adv Exp Med Biol. 491:587-630.
38. Katayama Y, Hidalgo A, Furie BC, Vestweber D, Furie B, Frenette PS. 2003. PSGL-1 participates in E-selectin-mediated progenitor homing to bone marrow: Evidence for cooperation between E-selectin ligands and alpha4 integrin. Blood. 102:2060-2067.
39. Kikuchi J, Shinohara H, Nonomura C, Ando H, Takaku S, Nojiri H, Nakamura M. 2005. Note core 2 beta 1,6-N-acetylglucosaminyltransferase-2 or -3 but -1 regulates sialyl-Lewis x expression in human precursor B cells. Glycobiology. 15:271-280.
40. Knibbs RN, Craig RA, Maly P, Smith PL, Wolber FM, Faulkner NE, Lowe JB, Stoolman LM. 1998. Alpha(1,3)-fucosyltransferase VII-dependent synthesis of P- and E-selectin ligands on cultured T lymphoblasts. J Immunol 161:6305-6315.
41. Knibbs RN, Craig RA, Natsuka S, Chang A, Cameron M, Lowe JB, Stoolman LM. 1996. The fucosyltransferase FucT-VII regulates E-selectin ligand synthesis in human T cells. J Cell Biol. 133:911-920.
42. Le Marer N, Palcic MM, Clarke JL, Davies D, Skacel PO. 1997. Developmental regulation of alpha 1,3-fucosyltransferase expression in CD34 positive progenitors and maturing myeloid cells isolated from normal human bone marrow. Glycobiology. 7:357-365.
43. Lehr JE, Pienta KJ. 1998. Preferential adhesion of prostate cancer cells to a human bone marrow endothelial cell line. J Natl Cancer Inst. 90:118-123.
44. Liepkalns VA, Eboue D, Beringer T, Sabri A, Icard-Liepkalns C. 1995. Repression of the Lewis fucosyl transferase by retinoic acid increases apical sialosyl Lewis(a) secretion in colorectal carcinoma cultures. J Cell Biochem. 58:292-304.
45. Liu F, Chen JH, Zhao JH, Fan J, Chen HL. 2000. Lewis Antigens, alpha1,3 fucosyltransferses and the metastatic potential of human primary liver cancer. Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai). 32:115-120.
46. Lowe JB. 2002. Glycosylation in the control of selectin counter-receptor structure and function. Immunol Rev. 186:19-36.
47. Lowe JB. 2003. Glycan-dependent leukocyte adhesion and recruitment in inflammation. Curr Opin Cell Biol. 15:531-538.
48. Lowe JB, Marth JD. 2003. A genetic approach to mammalian glycan function. Annu Rev Biochem. 72:643-691.
49. Mack DR, Cheng PW, Perini F, Wei S, Hollingsworth MA. 1998. Altered expression of sialylated carbohydrate antigens in HT29 colonic carcinoma cells. Glycoconj J. 15:1155-1163.
50. Majuri ML, Niemela R, Tiisala S, Renkonen O, Renkonen R. 1995. Expression and function of alpha 2,3-sialyl- and alpha 1,3/ 1,4-fucosyltransferases in colon adenocarcinoma cell lines: Role in synthesis of E-selectin counterreceptors. Int J Cancer. 63:551-559.
51. Martensson S, Bigler SA, Brown M, Lange PH, Brawer MK, Hakomori S. 1995. Sialyl-Lewis(x) and related carbohydrate antigens in the prostate. Hum Pathol. 26:735-739.
52. Martin-Satue M, de Castellarnau C, Blanco J. 1999. Overexpression of alpha(1,3)-fucosyltransferase VII is sufficient for the acquisition of lung colonization phenotype in human lung adenocarcinoma HAL-24Luc cells. Br J Cancer. 80:1169-1174.
53. Mas E, Pasqualini E, Caillol N, El Battari A, Crotte C, Lombardo D, Sadoulet MO. 1998. Fucosyltransferase activities in human pancreatic tissue: Comparative study between cancer tissues and established tumoral cell lines. Glycobiology. 8:605-613.
54. Matsuura N, Narita T, Hiraiwa N, Hiraiwa M, Murai H, Iwase T, Funahashi H, Imai T, Takagi H, Kannagi R. 1998. Gene expression of fucosyl- and sialyl-transferases which synthesize sialyl Lewis x, the carbohydrate ligands for E-selectin, in human breast cancer. Int J Oncol. 12:1157-1164.
55. McCurley RS, Recinos A VI, Olsen AS, Gingrich JC, Szczepaniak D, Cameron HS, Krauss R, Weston BW. 1995. Physical maps of human alpha (1,3)fucosyltransferase genes FUT3-FUT6 on chromosomes 19p13.3 and 11q21. Genomics. 26:142-146.
56. Miyoshi E, Moriwaki K, Nakagawa T. 2008. Biological function of fucosylation in cancer biology. J Biochem.
57. Naiyer AJ, Jo DY, Ahn J, Mohle R, Peichev M, Lam G, Silverstein RL, Moore MA, Rafii S. 1999. Stromal derived factor-1-induced chemokinesis of cord blood CD34(+) cells (long-term culture-initiating cells) through endothelial cells is mediated by E-selectin. Blood. 94:4011-4019.
58. Najy AJ, Day KC, Day ML. 2008. ADAM15 supports prostate cancer metastasis by modulating tumor cell-endothelial cell interaction. Cancer Res. 68:1092-1099.
59. Nakayama F, Nishihara S, Iwasaki H, Kudo T, Okubo R, Kaneko M, Nakamura M, Karube M, Sasaki K, Narimatsu H. 2001. CD15 expression in mature granulocytes is determined by alpha 1,3-fucosyltransferase IX, but in promyelocytes and monocytes by alpha 1,3-fucosyltransferase IV. J Biol Chem. 276:16100-16106.
60. Navone NM, Olive M, Ozen M, Davis R, Troncoso P, Tu SM, Johnston D, Pollack A, Pathak S, von Eschenbach AC, et al. 1997. Establishment of two human prostate cancer cell lines derived from a single bone metastasis. Clin Cancer Res. 3:2493-2500.
61. Nemeth JA, Cher ML, Zhou Z, Mullins C, Bhagat S, Trikha M. 2003. Inhibition of alpha(v)beta3 integrin reduces angiogenesis, bone turnover, and tumor cell proliferation in experimental prostate cancer bone metastases. Clin Exp Metastasis. 20:413-420.
62. Ni Z, Campbell JJ, Niehans G, Walcheck B. 2006. The monoclonal antibody CHO-131 identifies a subset of cutaneous lymphocyte-associated antigen T cells enriched in P-selectin-binding cells. J Immunol. 177:4742-4748.
63. Ogawa J, Inoue H, Koide S. 1996. Expression of alpha-1,3-fucosyltransferase type IV and VII genes is related to poor prognosis in lung cancer. Cancer Res. 56:325-329.
64. Petretti T, Schulze B, Schlag PM,Kemmner W. 1999. Altered mRNA expression of glycosyltransferases in human gastric carcinomas. Biochim Biophys Acta. 1428:209-218.
65. Phillips ML, Nudelman E, Gaeta FC, Perez M, Singhal AK, Hakomori S, Paulson JC. 1990. ELAM-1 mediates cell adhesion by recognition of a carbohydrate ligand, sialyl-Lex. Science. 250:1130-1132.
66. Sasaki N, Manya H, Okubo R, Kobayashi K, Ishida H, Toda T, Endo T, Nishihara S. 2005. Beta4GaIT-II is a key regulator of glycosylation of the proteins involved in neuronal development. Biochem Biophys Res Commun. 333:131-137.
67. Schottelius AJ, Hamann A, Asadullah K. 2003. Role of fucosyltransferases in leukocyte trafficking: Major impact for cutaneous immunity. Trends Immunol. 24:101-104.
68. Scott LJ, Clarke NW, George NJ, Shanks JH, Testa NG, Lang SH. 2001. Interactions of human prostatic epithelial cells with bone marrow endothelium: Binding and invasion. Br J Cancer. 84:1417-1423.
69. Serpa J, Mesquita P, Mendes N, Oliveira C, Almeida R, Santos-Silva F, Reis CA, LePendu J, David L. 2006. Expression of Lea in gastric cancer cell lines depends on FUT3 expression regulated by promoter methylation. Cancer Lett. 242:191-197.
70. Simpson MA, Reiland J, Burger SR, Furcht LT, Spicer AP, Oegema TR JrJr, McCarthy JB. 2001. Hyaluronan synthase elevation in metastatic prostate carcinoma cells correlates with hyaluronan surface retention, a prerequisite for rapid adhesion to bone marrow endothelial cells. J Biol Chem. 276:17949-17957.
71. Singh S, Singh UP, Grizzle WE, Lillard JWJrJr. 2004. CXCL12-CXCR4 interactions modulate prostate cancer cell migration, metalloproteinase expression and invasion. Lab Invest. 84:1666-1676.
72. Smithson G, Rogers CE, Smith PL, Scheidegger EP, Petryniak B, Myers JT, Kim DS, Homeister JW, Lowe JB. 2001. Fuc-TVII is required for T helper 1 and T cytotoxic 1 lymphocyte selectin ligand expression and recruitment in inflammation, and together with Fuc-TIV regulates naive T cell trafficking to lymph nodes. J Exp Med. 194:601-614.
73. Sun YX, Wang J, Shelburne CE, Lopatin DE, Chinnaiyan AM, Rubin MA, Pienta KJ, Taichman RS. 2003. Expression of CXCR4 and CXCL12 (SDF-1) in human prostate cancers (PCa) in vivo. J Cell Biochem. 89:462-473.
74. Taichman RS, Cooper C, Keller ET, Pienta KJ, Taichman NS, McCauley LK. 2002. Use of the stromal cell-derived factor-1/CXCR4 pathway in prostate cancer metastasis to bone. Cancer Res. 62:1832-1837.
75. Togayachi A, Kudo T, Ikehara Y, Iwasaki H, Nishihara S, Andoh T, Higashiyama M, Kodama K, Nakamori S, Narimatsu H. 1999. Up-regulation of Lewis enzyme (Fuc-TIII) and plasma-type alpha1,3fucosyltransferase (Fuc-TVI) expression determines the augmented expression of sialyl Lewis x antigen in non-small cell lung cancer. Int J Cancer. 83:70-79.
76. Torrado J, Correa P, Ruiz B, Bernardi P, Zavala D, Bara J. 1992. Lewis antigen alterations in gastric cancer precursors. Gastroenterology 102:424-430.
77. Wagers AJ, Lowe JB, Kansas GS. 1996. An important role for the alpha 1,3 fucosyltransferase, FucT-VII, in leukocyte adhesion to E-selectin. Blood. 88:2125-2132.
78. Walcheck B, Leppanen A, Cummings RD, Knibbs RN, Stoolman LM, Alexander SR, Mattila PE, McEver RP. 2002. The monoclonal antibody CHO-131 binds to a core 2 O-glycan terminated with sialyl-Lewis x, which is a functional glycan ligand for P-selectin. Blood. 99:4063-4069.
79. Wang QY, Wu SL, Chen JH, Liu F, Chen HL. 2003. Expressions of Lewis antigens in human non-small cell pulmonary cancer and primary liver cancer with different pathological conditions. J Exp Clin Cancer Res 22:431-440.
80. Weitz-Schmidt G, Stokmaier D, Scheel G, Nifant'ev NE, Tuzikov AB, Bovin NV. 1996. An E-selectin binding assay based on a polyacrylamide-type glycoconjugate. Anal Biochem. 238:184-190.
81. Weninger W, Ulfman LH, Cheng G, Souchkova N, Quackenbush EJ, Lowe JB, von Andrian UH. 2000. Specialized contributions by alpha(1,3)-fucosyltransferase-IV and FucT-VII during leukocyte rolling in dermal microvessels. Immunity. 12:665-676.
82. Weston BW, Hiller KM, Mayben JP, Manousos GA, Bendt KM, Liu R, Cusack JC JrJr. 1999. Expression of human alpha(1,3)fucosyltransferase antisense sequences inhibits selectin-mediated adhesion and liver metastasis of colon carcinoma cells. Cancer Res. 59:2127-2135.
83. Yamanaka K, Dimitroff CJ, Fuhlbrigge RC, Kakeda M, Kurokawa I, Mizutani H, Kupper TS. 2008. Vitamins A and D are potent inhibitors of cutaneous lymphocyte-associated antigen expression. J Allergy Clin Immunol. 121:148-157, e143.
84. Yoshida N, Yoshikawa T, Nakagawa S, Sakamoto K, Nakamura Y, Naito Y, Kondo M. 1999. Effect of shear stress and a stable prostaglandin I2 analogue on adhesive interactions of colon cancer cells and endothelial cells. Clin Exp Immunol. 117:430-434.